CBAN vs CARE
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Oct 22, 2026
CBAN
CARE
Investment Advisor Scores
CARE
AI Analyst Insights
Detailed Metrics Comparison
| Metric | CBAN | CARE | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 11.0011 | 13.6612 | CBAN |
| PEG Ratio | 2.1066 | 0 | Tie |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | 25.3% | 68.3% | CARE |
| Earnings Growth | 11.5% | 253.9% | CARE |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 59.2/100 | 63.4/100 | CARE |
| Profit Margin | 22.5% | 44.9% | CARE |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | STRONG BUY | STRONG BUY | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
CBAN
DistributionPrice near a flattening SMA50 (slope -3.0%) with fading momentum, RSI 49
CARE
NeutralMixed signals - no dominant trend phase, RSI 53
Fundamentals Snapshot
| Metric | CBAN | CARE |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 8.5 | 11.8 |
| Trailing P/E | 11.9 | 5.2 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.3% | 0.7% |
| Gross Margin | 1.0% | 1.0% |
| Operating Margin | 0.4% | 0.6% |
| EPS | 1.66 | 5.83 |
| Dividend Yield | 0.02% | 0.00% |